⚕️
Sağlık Hizmetleri Sektörü Hisseleri
Sağlık Hizmetleri Sektörü altında 807 Hisse Senedi
Sağlık Hizmetleri sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
100
Toplam Hisse
$28.6B
Toplam Piyasa Değeri
Sağlık Hizmetleri Sektörü Hisseleri
Sayfa 5/9 (Toplam: 807)
SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
---|---|---|---|---|
ARCT | Arcturus Therapeutics Holdings Inc. | $405.45M | $14.95 | 3.24% |
GOSS | Gossamer Bio, Inc. | $404.60M | $1.78 | 4.81% |
CYRX | Cryoport, Inc. | $400.09M | $7.98 | 2.18% |
QSI | Quantum-Si incorporated | $399.36M | $1.98 | 5.32% |
ALMS | Alumis Inc. Common Stock | $398.31M | $3.86 | 0.52% |
AIRS | AirSculpt Technologies, Inc. | $392.58M | $6.29 | 2.48% |
ITOS | iTeos Therapeutics, Inc. | $388.48M | $10.15 | 0.20% |
VIGL | Vigil Neuroscience, Inc. | $383.88M | $8.05 | 0.25% |
CTMX | CytomX Therapeutics, Inc. | $376.53M | $2.39 | 1.65% |
NMRA | Neumora Therapeutics, Inc. Common Stock | $370.40M | $2.29 | 23.78% |
ANGO | AngioDynamics, Inc. | $370.17M | $9.11 | 1.09% |
CRVS | Corvus Pharmaceuticals, Inc. | $366.29M | $4.75 | 1.71% |
RIGL | Rigel Pharmaceuticals, Inc. | $365.13M | $20.43 | 3.04% |
TMCI | Treace Medical Concepts, Inc. | $364.22M | $5.79 | 4.77% |
SPOK | Spok Holdings, Inc. | $362.90M | $17.64 | 0.68% |
GLUE | Monte Rosa Therapeutics, Inc. | $351.22M | $5.71 | 4.19% |
SLQT | SelectQuote, Inc. | $350.62M | $2.03 | 7.31% |
RNAC | Cartesian Therapeutics, Inc. | $349.34M | $13.46 | 0.52% |
TBRG | TruBridge, Inc. | $349.29M | $23.25 | 0.61% |
EHAB | Enhabit, Inc. | $348.89M | $6.89 | 0.43% |
RCKT | Rocket Pharmaceuticals, Inc. | $345.84M | $3.21 | 4.46% |
FHTX | Foghorn Therapeutics Inc. | $345.04M | $6.19 | 4.33% |
ABEO | Abeona Therapeutics Inc. | $340.19M | $6.65 | 0.89% |
TOI | The Oncology Institute, Inc. | $335.49M | $3.65 | 1.62% |
INBX | Inhibrx Biosciences, Inc. | $333.96M | $23.07 | 0.56% |
ALT | Altimmune, Inc. | $333.35M | $4.11 | 4.20% |
ALLO | Allogene Therapeutics, Inc. | $330.28M | $1.51 | 9.04% |
TNXP | Tonix Pharmaceuticals Holding Corp. | $329.01M | $44.72 | 1.76% |
OCGN | Ocugen, Inc. | $327.07M | $1.12 | 4.27% |
ALDX | Aldeyra Therapeutics, Inc. | $325.83M | $5.44 | 1.63% |
NGNE | Neurogene Inc. | $325.32M | $22.81 | 1.21% |
RXST | RxSight, Inc. | $322.66M | $7.94 | 0.51% |
NRC | National Research Corporation | $321.73M | $14.12 | 4.14% |
AVIR | Atea Pharmaceuticals, Inc. | $320.07M | $3.74 | 7.16% |
VREX | Varex Imaging Corporation | $313.32M | $7.55 | 1.82% |
SGMT | Sagimet Biosciences Inc. | $312.88M | $10.20 | 6.36% |
OLMA | Olema Pharmaceuticals, Inc. | $312.69M | $4.57 | 1.93% |
BNTC | Benitec Biopharma Inc. | $312.64M | $11.91 | 0.51% |
OM | Outset Medical, Inc. | $312.09M | $17.61 | 9.41% |
XOMA | XOMA Corporation | $308.87M | $25.81 | 0.46% |
SCPH | scPharmaceuticals Inc. | $308.31M | $5.84 | 8.75% |
CATX | Perspective Therapeutics, Inc. | $308.05M | $4.15 | 4.60% |
NPCE | NeuroPace, Inc. | $297.48M | $9.07 | 4.53% |
CAPR | Capricor Therapeutics, Inc. | $296.19M | $6.48 | 4.99% |
ESPR | Esperion Therapeutics, Inc. | $295.32M | $1.49 | 12.03% |
STIM | Neuronetics, Inc. | $294.21M | $4.45 | 0.23% |
VSTM | Verastem, Inc. | $290.68M | $5.29 | 1.12% |
HRTX | Heron Therapeutics, Inc. | $289.87M | $1.90 | 3.06% |
MNPR | Monopar Therapeutics Inc. | $286.31M | $46.82 | 0.11% |
VNDA | Vanda Pharmaceuticals Inc. | $282.30M | $4.79 | 1.03% |
ANNX | Annexon, Inc. | $279.77M | $2.55 | 2.82% |
NATR | Nature's Sunshine Products, Inc. | $274.55M | $14.87 | 2.24% |
EDIT | Editas Medicine, Inc. | $272.90M | $3.26 | 5.78% |
LFCR | Lifecore Biomedical, Inc. | $272.14M | $7.35 | 2.39% |
VOR | Vor Biopharma Inc. | $271.16M | $2.17 | 3.83% |
CDXS | Codexis, Inc. | $268.42M | $3.24 | 2.70% |
HCAT | Health Catalyst, Inc. | $267.96M | $3.85 | 4.94% |
TSVT | 2seventy bio, Inc. | $266.14M | $5.00 | 0.00% |
MASS | 908 Devices Inc. | $264.66M | $7.38 | 0.68% |
SLP | Simulations Plus, Inc. | $264.07M | $13.12 | 1.13% |
LCTX | Lineage Cell Therapeutics, Inc. | $262.61M | $1.15 | 6.48% |
CERS | Cerus Corporation | $259.98M | $1.36 | 6.21% |
INZY | Inozyme Pharma, Inc. | $258.25M | $4.00 | 0.25% |
OPRX | OptimizeRx Corporation | $257.82M | $13.94 | 1.23% |
QTRX | Quanterix Corporation | $257.07M | $5.51 | 3.16% |
OABI | OmniAb, Inc. | $256.55M | $2.12 | 1.40% |
VMD | Viemed Healthcare, Inc. | $248.60M | $6.29 | 2.63% |
OSUR | OraSure Technologies, Inc. | $248.34M | $3.32 | 0.61% |
THRD | Third Harmonic Bio, Inc. | $244.59M | $5.42 | 0.18% |
TRDA | Entrada Therapeutics, Inc. | $242.52M | $6.39 | 0.08% |
MXCT | MaxCyte, Inc. | $241.34M | $2.27 | 2.58% |
LRMR | Larimar Therapeutics, Inc. | $240.10M | $3.75 | 0.27% |
REPL | Replimune Group, Inc. | $238.97M | $3.10 | 7.05% |
TCMD | Tactile Systems Technology, Inc. | $238.30M | $10.25 | 2.19% |
SKIN | The Beauty Health Company | $230.60M | $1.83 | 9.41% |
DSGN | Design Therapeutics, Inc. | $229.35M | $4.04 | 5.39% |
SLRN | Acelyrin, Inc. | $229.17M | $2.27 | 0.00% |
SMTI | Sanara MedTech Inc. | $227.97M | $25.65 | 6.32% |
VTYX | Ventyx Biosciences, Inc. | $227.72M | $3.20 | 0.95% |
DRUG | Bright Minds Biosciences Inc. | $226.59M | $31.99 | 7.06% |
ELDN | Eledon Pharmaceuticals, Inc. | $223.36M | $3.73 | 2.10% |
YMAB | Y-mAbs Therapeutics, Inc. | $219.23M | $4.84 | 0.62% |
CRLBF | Cresco Labs Inc. | $213.76M | $0.63 | 4.39% |
FDMT | 4D Molecular Therapeutics, Inc. | $213.56M | $4.61 | 2.12% |
CVRX | CVRx, Inc. | $213.53M | $8.19 | 4.77% |
TIL | Instil Bio, Inc. | $211.49M | $32.24 | 8.66% |
OMER | Omeros Corporation | $210.35M | $3.59 | 6.02% |
RAPT | RAPT Therapeutics, Inc. | $209.18M | $12.65 | 9.25% |
CRGX | CARGO Therapeutics, Inc. Common Stock | $208.43M | $4.52 | 0.89% |
MGRM | Monogram Orthopaedics, Inc. | $206.83M | $5.72 | 0.35% |
STXS | Stereotaxis, Inc. | $202.16M | $2.24 | 1.75% |
VRNOF | Verano Holdings Corp. | $201.80M | $0.56 | 6.50% |
TVGN | Tevogen Bio Holdings Inc. | $198.69M | $1.07 | 0.93% |
RPID | Rapid Micro Biosystems, Inc. | $190.23M | $4.34 | 7.69% |
UTMD | Utah Medical Products, Inc. | $188.59M | $58.06 | 0.21% |
GALT | Galectin Therapeutics Inc. | $186.08M | $2.94 | 4.26% |
SGHT | Sight Sciences, Inc. | $184.06M | $3.56 | 5.70% |
KYTX | Kyverna Therapeutics, Inc. | $183.25M | $4.24 | 2.08% |
VYGR | Voyager Therapeutics, Inc. | $183.16M | $3.31 | 0.91% |
INGN | Inogen, Inc. | $182.83M | $6.80 | 1.04% |